Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Non-Communicable Disease Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Cardiothorac Surg. 2023 Jul 28;18(1):240. doi: 10.1186/s13019-023-02333-y.
Although low-density lipoprotein-cholesterol (LDL-C) level is considered one of the main prognostic factors in patients with coronary artery bypass grafting (CABG), the question about "the lower the better" is still unanswered. We aimed to evaluate and compare the outcomes of patients with CABG and low or very low baseline LDL-C, regardless of statin usage.
In this registry-based cohort study, 10,218 patients with low/very low (70-100 and ≤ 70 mg/dL) baseline LDL-C who underwent isolated and the first-time CABG without known previous history of cardio-cerebrovascular events, were included and compared. The median follow-up was 73.33 (72.15-74.51) months. Primary outcomes were all-cause mortality and major adverse cardio-cerebrovascular events (MACCE) (consisted of all-cause mortality, acute coronary syndrome, stroke or transient ischemic attack, and the need for repeat revascularization [percutaneous coronary intervention or redo-CABG]). Cox regression analyses before and after the propensity score matching (PSM) model were applied to evaluate and compare outcomes.
The mean age of the study population was 66.17 ± 9.98 years old and 2506 (24.5%) were women. Diabetes mellitus and a history of cigarette smoking were significantly higher in the very low LDL group (P-value ≤ 0.001). In Cox regression analyses before applying PSM model, both all-cause mortality (14.2% vs. 11.9%, P-value = 0.004 and MACCE (26.0% vs. 23.6%, P-value = 0.006) were significantly higher in the very low LDL group compared to low LDL. However, these results were no longer significant after applying the PSM model (all-cause mortality HR: 1.115 [95% CI: 0.986-1.262], P = 0.083 and MACCE HR: 1.077 [95%CI: 0.984-1.177], P = 0.095). The sensitivity analysis to remove the statin effect demonstrated that very low LDL-C level was correlated to higher risk of all-cause mortality in both unmatched and PSM analyses.
Very low serum LDL-C levels (≤ 70 mg/dl) could increase long-term all-cause mortality and cardiovascular events in patients who have undergone isolated CABG.
尽管低密度脂蛋白胆固醇(LDL-C)水平被认为是冠状动脉旁路移植术(CABG)患者的主要预后因素之一,但“越低越好”的问题仍未得到解答。我们旨在评估和比较基线 LDL-C 水平低或极低(70-100 和≤70mg/dL)且无论是否使用他汀类药物的 CABG 患者的结局。
在这项基于登记的队列研究中,纳入了 10218 名基线 LDL-C 水平低/极低(70-100 和≤70mg/dL)且无已知先前心脑血管事件史的接受单纯和首次 CABG 的患者,并进行了比较。中位随访时间为 73.33(72.15-74.51)个月。主要结局是全因死亡率和主要不良心脑血管事件(MACCE)(包括全因死亡率、急性冠状动脉综合征、卒中和短暂性脑缺血发作以及需要再次血运重建[经皮冠状动脉介入治疗或再次 CABG])。在倾向评分匹配(PSM)模型前后应用 Cox 回归分析来评估和比较结局。
研究人群的平均年龄为 66.17±9.98 岁,2506 名(24.5%)为女性。极低 LDL 组的糖尿病和吸烟史明显更高(P 值≤0.001)。在应用 PSM 模型前的 Cox 回归分析中,极低 LDL 组的全因死亡率(14.2%比 11.9%,P 值=0.004)和 MACCE(26.0%比 23.6%,P 值=0.006)均显著更高。然而,应用 PSM 模型后,这些结果不再具有统计学意义(全因死亡率 HR:1.115[95%CI:0.986-1.262],P=0.083;MACCE HR:1.077[95%CI:0.984-1.177],P=0.095)。敏感性分析去除他汀类药物的影响表明,在未匹配和 PSM 分析中,极低 LDL-C 水平与全因死亡率升高相关。
在接受单纯 CABG 的患者中,极低的血清 LDL-C 水平(≤70mg/dl)可增加长期全因死亡率和心血管事件风险。